Prof. Christoph Lange, Head of the Clinical Tuberculosis Infrastructure at the German Center for Infection Research (DZIF) and Medical Director of the Borstel Research Center, Leibniz Lung Center, has
At the DZIF partner site in Giessen, a ceremonial kickoff meeting marked the launch of the GUARDIAN research project, which is funded with 3.5 million euros by the Federal Ministry of Research
Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of
The Institute of Infectious Diseases and Tropical Medicine has announced the inclusion of the first study participant in the STEP2C Stage 3 trial. The study is part of the international UNITE4TB
He is one of the world's leading clinical researchers in the field of tuberculosis (TB): Prof. Dr. Dr. h. c. Christoph Lange has been awarded the DZIF Prize for Translational Infection Research 2025
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study, led by
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address
Urinary tract infections are among the most common reasons for prescribing antibiotics. Since conventional pathogen identification in the laboratory usually takes two to three days, initial treatment
Most malaria drugs are combination therapies based on artemisinin, an active ingredient derived from the medicinal plant Artemisia annua (sweet wormwood). The malaria parasite Plasmodium falciparum is
